Exhibit 99.1

     Balchem Corporation to Purchase the Marano Ticino Choline Chloride and
                      Methylamines Business of Akzo Nobel

         New Hampton,  New York,  April 2, 2007 - Balchem  Corporation  (NASDAQ:
BCPC) today announced that its European subsidiary,  Balchem,  B.V. entered into
an agreement under which it will acquire the choline  chloride and  methylamines
businesses located in Marano Ticino, Italy from Akzo Nobel Chemicals S.p.A. Akzo
Nobel is a  global  leader  in the  chemical  industry,  and its  Marano  Ticino
operation employs  approximately  eighty people,  manufacturing and distributing
choline, methylamines and derivative products to customers around the world.

         "This acquisition provides a production platform that will enable us to
better serve the expanding  worldwide  human and animal choline  chloride demand
and it also  adds a  direct  commercial  European  presence,  which  we now deem
necessary.  In  addition  to choline  nutritional  products,  we gain  access to
production and technology for methylamines,  metam sodium and other products for
various industrial applications. This platform should provide many opportunities
for Balchem to leverage its global growth plans," said Dino A. Rossi, President,
CEO and Chairman of the Board of Directors of Balchem.

         In 2006, this Akzo operation  realized  approximately  US$35 million in
revenue.  This  revenue,  when  added to  Balchem's  2006  result  and its other
acquisition in 2007,  raises  Balchem  revenues on a pro forma basis for 2006 to
approximately $175 million from $101 million.

         Choline  chloride is an essential  nutrient for optimum  animal growth,
and is integral in building, regulating, and maintaining cell membrane integrity
and porosity.  It also acts as a lipotropic agent, which aids in the utilization
and outward transport of fat in the liver.  Choline chloride and its derivatives
are also used in many other  industrial  applications.  Methylamines are used as
raw  materials for the  production  of choline  chloride and also widely used in
many chemical and industrial applications.

         The parties  estimate the transaction will close within the next thirty
to sixty  days after  satisfaction  of  customary  conditions  contained  in the
agreement.  For additional  details regarding this transaction,  please refer to
Balchem's  Form 8-K to be filed with the US Securities  and Exchange  Commission
(www.sec.gov).

About Balchem Corporation
Balchem Corporation consists primarily of three business segments: ARC Specialty
Products,   Encapsulated/Nutritional   Products,   and  BCP   Ingredients,   our
unencapsulated feed supplements segment. Through ARC Specialty Products, Balchem
provides   specialty-packaged   chemicals  for  use  in  healthcare   and  other
industries.   The   Encapsulated/Nutritional    segment   provides   proprietary
microencapsulation  solutions  to an  expanding  variety  of  applications.  BCP
Ingredients  manufactures  and supplies  choline  chloride and derivatives  used
primarily in the poultry and swine industries.


Contact:   Frank Fitzpatrick, Chief Financial Officer
           Telephone:  845-326-5600